株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CMO (医薬品製造受託機関) の世界市場における成長機会:2024年までの予測

Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024

発行 Frost & Sullivan 商品コード 918942
出版日 ページ情報 英文 144 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.10円で換算しております。
CMO (医薬品製造受託機関) の世界市場における成長機会:2024年までの予測 Growth Opportunities in the Global Pharmaceutical Contract Manufacturing Organization Market (CMO), Forecast to 2024
出版日: 2019年12月02日 ページ情報: 英文 144 Pages
概要

オーファンドラッグ (希少疾病用医薬品) セグメントおよびオーダーメイド医療における新たな需要への対応に必要とされる連続生産技術の進歩は、CMO (医薬品製造受託機関) は新たな成長ベクトルを提供する見込みです。

当レポートでは、世界の医薬品有効成分/原薬 (API) および最終製剤 (FDF) 製造向けCMO (医薬品製造受託機関) 市場について調査し、世界市場の規模・成長予測・最大セグメント、地域別の市場機会、中小企業にとって最大の機会、主なビジネスモデル、競合情勢などについて分析しています。

エグゼクティブダッシュボード

市場概要

  • 範囲・地域区分
  • 区分
  • ベンダー情勢
  • 医薬品バリューチェーンにおけるCMOの役割の拡大
  • Capexの成長動向
  • CMO:医薬品不足の発生に対する答え
  • 主な市場成長の抑制要因
  • 世界の政策変化の提供
  • 世界の展望
  • 主な世界の動向

市場ダイナミクス

  • 回復したパイプラインが成長を促進
  • 下落、しかしジェネリック医薬品区分は成長が続く
  • アウトソーシングの展望:エンドユーザー別
  • アウトソーシング:開発段階別
  • 製造を改革する新しい技術動向
  • 連続生産における成長の推進力
  • 3Dプリント
  • CMOエンゲージメントモデル
  • 進化するビジネスモデル

収益予測

  • 予測手法・前提条件
  • 市場エンジニアリング測定
  • 収益予測:製品タイプ別
  • 収益予測:地域別

収益予測:API

  • API CMO市場:収益予測、顧客基盤別
  • API CMO市場:収益予測、地域別
  • 収益予測の議論
  • API情勢

収益予測:FDF

  • FDF CMO市場:収益予測、調合タイプ別
  • FDF CMO市場:収益予測、地域別
  • 収益予測の議論

収益予測:米国

  • API CMO市場:収益予測、顧客基盤別
  • FDF CMO市場:収益予測、調合タイプ別

収益予測:ドイツ

収益予測:英国

収益予測:フランス

収益予測:イタリア

収益予測:スペイン

収益予測:スカンジナビア

収益予測:ベネルクス諸国

収益予測:インド

収益予測:中国

収益予測:日本

競合情勢

主なコラボレーション合意

成長機会

  • 主な成長機会
  • 成長機会1:規制薬物
  • 成長機会2:スケーラブルスマートパッケージング
  • 成長機会3:MENAにおけるFDFの製造
  • 成長機会4:強力なAPI
  • 成長機会5:スマートマニュファクチャリング

結論

付録

目次
Product Code: MEF6-52

Advancements in Continuous Manufacturing Technology, Necessary to Meet New Demand in the Orphan Drugs Segment and Personalized Medicine, Will Give a New Growth Vector to CMOs

Traditionally, CMOs have thrived by aggregating demand and delivering benefits of economies of scale. However, with the fading era of blockbuster drugs dispensed to large patient pools and shift to precision medicine, focus on niche indications, and increased R&D in biologics, pharma sponsors are increasingly turning to CMOs as strategic partners instead of contractors. Sponsors are looking for partnerships to not only append their existing capacity and get access to new markets, but also to mitigate risk and bring overhaul in manufacturing technologies. Consequently, safety, efficacy, and product quality are outweighing cost-saving considerations.

CMOs are also stepping up to the growing demand by investing in containment technology to meet HPAPI demand, introducing distributed manufacturing to take manufacturing closer to the patient, and adopting continuous manufacturing and digitization of processes. For example, CMOs are partnering with third-party vendors for layered analytics with the aim of optimizing processes, introducing preventive maintenance, and making supply chains transparent. This research service covers these technology trends with case examples of how some CMOs are ahead of the curve in adopting these technologies.

This study also covers the global market for pharmaceutical contract manufacturing for Active Pharmaceutical Ingredient (API) and Finished Dosage Form (FDF) manufacturing. It provides a comprehensive and critical analysis of subsectors, including generic APIs, novel APIs, HPAPIs, solid dosage forms, and injectable dosages. The study also examines top developed and emerging national markets, challenges in each of these markets, and hidden opportunities. For example, in the US, where generic drug penetration is heavy at almost 80% and China, India, Russia, and Mexico where levels are as high as 90%, the CMO market has reached saturation and, therefore, CMOs can explore opportunities in lifecycle management of legacy products and redesigning synthesis routes to create high-tech generics.

This study also captures sponsors' outlook for outsourcing by products and by stage of drug lifecycle and the new engagement models being sought. In conjunction with the opportunities in product selection and manufacturing technologies, the study also has a detailed discussion on opportunities in the packaging segment in the light of new serialization requirements, track-and-trace solutions designed to reduce to counterfeit medicine, primary and secondary packaging to meet regional and local regulatory requirements, as well as opportunities to collaborate with CROs for new drug development. The study also discusses the impact of ongoing consolidation, profiles of leading CMOs, key CMOs to watch for, and, most importantly, the interest of private equity firms in the segment.

Key Issues Addressed:

  • What is the total market size and projected growth of the global pharmaceutical contract manufacturing market? Which are the largest growth segments to be pursued?
  • How are the various regions around the globe positioned to monetize the market opportunities? What are the key regional barriers to entry?
  • Which are the biggest opportunities for small- and mid-sized companies in the highly fragmented market? What are the key challenges in the near and mid term?
  • How are business models evolving across the value chain and impacting the different stakeholders?
  • How are product offerings in this market likely to emerge? What is the rate of innovation adoption, and how is it solving the unmet needs of customers?
  • Which are the key game-changing companies in the segment and how are they riding the growth curve?

Table of Contents

Executive Dashboard

  • Purpose of this Study
  • 5-step Process to Transformational Growth
  • Key Findings
  • Key Findings (continued)
  • Key Questions this Study will Answer
  • Market Engineering Measurements
  • Big Market Themes
  • Strategic Imperatives for Success and Growth
  • Key Trends Impacting the CMO Industry

Market Overview

  • Scope and Geographic Segmentation
  • Segmentation
  • Vendor Landscape
  • Key Market Drivers
  • Expanding Role of CMOs in the Pharma Value Chain
  • Capex Growth Trends
  • CMOs-An Answer to the Drug Shortage Epidemic
  • Key Market Restraints
  • Implications of Global Policy Changes
  • Global Outlook
  • Main Global Trends

Market Dynamics

  • Rejuvenated Pipelines Driving Growth
  • Declining but Continued Growth in the Generics Segment
  • Outsourcing Outlook by End User
  • Outsourcing by Stage of Development
  • New Technology Trends Revolutionizing Manufacturing
  • Growing Impetus in Continuous Manufacturing
  • 3D Printing-Manufacturing the Drug Closer to the Patient
  • CMO Engagement Models
  • Evolving Business Model

Revenue Forecast

  • Methodology and Assumptions
  • Market Engineering Measurements
  • Revenue Forecast by Product Type
  • Revenue Forecast by Region

Revenue Forecast-API

  • API CMO Market-Revenue Forecast by Customer Base
  • API CMO Market-Revenue Forecast by Region
  • Revenue Forecast Discussion
  • API Landscape

Revenue Forecast-FDF

  • FDF CMO Market-Revenue Forecast by Formulation Type
  • FDF CMO Market-Revenue Forecast by Region
  • Revenue Forecast Discussion
  • Revenue Forecast Discussion (continued)

Revenue Forecast-US

  • US API CMO Market-Revenue Forecast by Customer Base
  • US FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-Germany

  • Germany API CMO Market-Revenue Forecast by Customer Base
  • Germany FDF CMO Market-Revenue Forecast by Formulation Type
  • Growth Driver-Clinical Trials

Revenue Forecast-UK

  • UK API CMO Market-Revenue Forecast by Customer Base
  • UK FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-France

  • France API CMO Market-Revenue Forecast by Customer Base
  • France FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-Italy

  • Italy API CMO Market-Revenue Forecast by Customer Base
  • Italy FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-Spain

  • Spain API CMO Market-Revenue Forecast by Customer Base
  • Spain FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-Scandinavia

  • Scandinavia API CMO Market-Revenue Forecast by Customer Base
  • Scandinavia FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-Benelux

  • Benelux API CMO Market-Revenue Forecast by Customer Base
  • Benelux FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-India

  • India API CMO Market-Revenue Forecast by Customer Base
  • India FDF CMO Market-Revenue Forecast by Formulation Type

Revenue Forecast-China

  • China API CMO Market-Revenue Forecast by Customer Base
  • China FDF CMO Market-Revenue Forecast by Formulation Type
  • Barriers to Serving Regulated Markets

Revenue Forecast-Japan

  • Japan API CMO Market-Revenue Forecast by Customer Base
  • Japan FDF CMO Market-Revenue Forecast by Formulation Type

Competitive Landscape

  • Competitive Environment
  • Market Share Analysis
  • Revenues of Key Companies
  • Manufacturing Footprint
  • Key Companies to Watch
  • Key Companies to Watch (continued)
  • Key Companies to Watch (continued)
  • Key Themes in the Collaboration/Expansion Landscape

Key Collaboration Agreements in the Contract Manufacturing Market

  • Expansion Assessment
  • Collaboration Assessment
  • Collaboration Assessment (continued)
  • Thermo Fisher and Patheon-Redefining One-stop-shop
  • Growing PE Interest-The Required Leverage for Scale-up

Growth Opportunities

  • Major Growth Opportunities
  • Growth Opportunity 1-Controlled Substances
  • CMOs Positioned to Capitalize on Medical Marijuana Market
  • Growth Opportunity 2-Scalable Smart Packaging
  • Addressable Market Opportunity-Smart Packaging
  • Illustrative Smart Packaging Solutions
  • Amplifying Smart Packaging Utility-Trek Therapeutics Uses Ambrosus' Blockchain Solution for Quality Control
  • Growth Opportunity 3-Manufacturing FDF in MENA
  • MENA Regional Developments
  • Examples of Strategies at Work
  • Key Companies to Watch in the MENA Region
  • Growth Opportunity 4-High Potency API
  • HPAPI Market Potential
  • Growth Opportunity 5-Smart Manufacturing
  • Top Technologies to Watch For
  • Case Study of IIoT Implementation-Decisyon's Solution
  • Growth Opportunity Matrix

The Last Word-Strategic Considerations for Staying on the Growth Trajectory

  • Top 3 Predictions for the Market
  • Winning Strategies for CMOs
  • Legal Disclaimer

Appendix

  • Abbreviations
  • Appendix-Medical Cannabis
  • Appendix-Pharma and Biotech Market in MENA Region
  • Leading ICT Participants Active in Life Science
  • API CMO Evolution Path
  • FDF CMO Industry Evolution
  • Growth Denominators
  • Growth Opportunity-Alleviating Data Integrity Issues
  • Data Integrity Statistics
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)